IPO

Dr. Agarwals Health Care Ltd. IPO

Min Investment
₹ 14,070 / 35 shares
Price Range
₹382 - ₹ 402
Bidding Dates
29 Jan '25 - 31 Jan '25
Total Issue Value
3,027.26 Cr
Lot Size
35
Total Issue Size
3,027.26 Cr
Listing At
BSE, NSE
Subscription
1.40 times
BSE Price
507.50 (26.24%)
NSE Price
508.35 (26.46%)

IPO Timeline

  • 29 Jan 2025
    Bidding Starts
  • 31 Jan 2025
    Bidding Ends
  • 3 Feb 2025
    Allotment Finalization
  • 5 Feb 2025
    Listing

About Dr. Agarwals Health Care Ltd.

We provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories, and eye care related pharmaceutical products. We endeavour to address all the needs of ... Read more

Parent organisation
Founded
Dr. Agarwals Health Care Ltd.
2010

Dr. Agarwals Health Care Ltd. IPO Reservation

Investors Category Shares Offered
Anchor Investors 2,17,78,799 (28.92%)
Employee Reserved 15,79,399 (2.1%)
Non Institutional Investors 1,08,89,400 (14.46%)
Qualified Institutional Buyers (QIBs) 1,45,19,200 (19.28%)
Retail Individual Investors (RIIs) 2,54,08,599 (33.74%)
Shareholder Reservation 11,29,574 (1.5%)

Dr. Agarwals Health Care Ltd. Financial Information

Year End Revenue PAT Reserves & Surplus
31 Mar 2025 1,097.70 Cr 35.93 Cr 1,902.05 Cr
31 Mar 2024 882.34 Cr 33.12 Cr 1,217.85 Cr
31 Mar 2023 615.34 Cr 60.79 Cr 553.63 Cr

Dr. Agarwals Health Care Ltd. Background

Major Events And Milestones
  • 2010
    Incorporation of our Company.
    Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.
  • 2011
    Investment by EILSF SPV 3 in our Company.
  • 2012
    Entry into the Africa market by entering into an agreement with Dr, Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.
  • 2017
    Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.
  • 2019
    Investment by Claymore Investments (Mauritius) Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.
    Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.
  • 2021
    Our Company launched its 100th eye care facility.
  • 2022
    Investment by TPG Capital’s Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd., an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.
    Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.
    Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP, Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani
  • 2023
    Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh
  • 2024
    Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.
    Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.
Dr. Agarwals Health Care Ltd. Object of Issues

1. Repayment/prepayment, in part or full, of certain of our borrowings
2. General corporate purposes and unidentified inorganic acquisition

Dr. Agarwals Health Care Ltd. IPO Listing Details
Listing Date
5 Feb 2025
BSE Script Code
544350
NSE Symbol
AGARWALEYE
ISIN
INE943P01029
Final Issue Price
₹ 402
Dr. Agarwals Health Care Ltd. Listing Day Trading Information
Pricing Details BSE NSE
Issue Price ₹ 402.00 ₹ 402.00
Open ₹ 396.90 ₹ 402.00
Low ₹ 370.10 ₹ 370.20
High ₹ 412.75 ₹ 412.90
Last Trade ₹ 401.55 ₹ 401.65
Dr. Agarwals Health Care Ltd. Company Promoters

1. Dr. Amar Agarwal
2. Dr. Athiya Agarwal
3. Dr. Adil Agarwal
4. Dr. Anosh Agarwal
5. Dr. Ashvin Agarwal
6. Dr. Ashar Agarwal
7. Dr. Amar Agarwal Family Trust
8. Dr. Adil Agarwal Family Trust
9. Dr. Anosh Agarwal Family Trust
10. Dr. Ashvin Agarwal Family Trust
11. Dr. Ashar Agarwal Family Trust
12. Dr. Agarwal’s Eye Institute
13. Dr. Agarwal's Eye Institute Private Limited

Industry Overview

According to the CRISIL MI&A Report, the eye care market in India has grown at a compounded annual growth rate of 11.5% between the Financial Years 2019 and 2024 to reach the value of ?378 billion in the Financial Year 2024. This market includes surgical and non-surgical treatments for ... Read more

Dr. Agarwals Health Care Ltd. Contact Details
Address: 1st Floor, Buhari Towers, No.4 Moores Road, Off Greams Road, Near Asan Memorial School, Chennai (Madras) Tamil Nadu - 600006
Phone no:43787777
43787777
|
Dr. Agarwals Health Care Ltd. IPO Registrar
KFin Technologies Ltd.
Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally Hyderabad Telangana - 500032
67162222
Dr. Agarwals Health Care Ltd. IPO Lead Manager(s)
Morgan Stanley India Company Pvt. Ltd.
Altimus, Level 39 & 40, Pandurang Budhkar Marg, Worli, Mumbai Maharashtra - 400013
61181000

FAQs

When does Dr. Agarwals Health Care Ltd. IPO opens and closes?

Dr. Agarwals Health Care Ltd. IPO opens from 29th January to 31st January 2025.

What is the size of Dr. Agarwals Health Care Ltd. IPO?

The size of the Dr. Agarwals Health Care Ltd. IPO is ₹3,027.26 Cr.

What is the price range of Dr. Agarwals Health Care Ltd. IPO?

The price range of Dr. Agarwals Health Care Ltd. IPO is at ₹382 to ₹402 per share.

What is the minimum investment and lot size required for the Dr. Agarwals Health Care Ltd. IPO?

The minimum investment required is ₹14,070 and minimum lot size is 35 shares.

When is Dr. Agarwals Health Care Ltd. IPO listing date?

The Dr. Agarwals Health Care Ltd. IPO will be listed on 5th February 2025.

What is the objective of Dr. Agarwals Health Care Ltd. IPO?

1. Repayment/prepayment, in part or full, of certain of our borrowings
2. General corporate purposes and unidentified inorganic acquisition

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+